Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
149 Leser
Artikel bewerten:
(0)

Havas Health & You Names Ad Industry Veteran John Hackney CEO of European Union

NEW YORK, Sept. 5, 2018 /PRNewswire/ -- Havas Health & You (HH&Y), the health and wellness marketing network focused on promoting healthy living decisions across the entire health spectrum, today announced that John Hackney has been appointed its CEO of EU. He will oversee Havas Health & You's vast agencies across the European Union.

With over 30 years of experience in advertising and health marketing communications, Hackney has run both regional and multi-national accounts and operated companies at some of the world's largest and most successful communications groups, including global agency networks like McCann Health and Young & Rubicam.

"We couldn't ask for a more dynamic person to oversee our agencies in the EU," said Donna Murphy, Global CEO of Havas Health & You. "John has worked with some of the biggest brands in the world-Coca-Cola, Unilever, Johnson & Johnson, Diageo, Bacardi and Pfizer-and has exceled at developing integrated teams, which will add to our culture of together. We can't wait to see how he will put this body of experience to work for us and our clients in Europe."

Hackney will be based in London and will report into Murphy.

"I honestly thought my next career move would signal the beginning of my global pop career," said Hackney, who has played guitar in several touring rock groups over the years. "But my teenage daughters weren't so convinced, so the next best thing is certainly stepping up as the European CEO for Havas Health & You. Since Havas Health rebranded as Havas Health & You last year, combining its health and wellness offerings and agencies around the world, my unique experiences will continue to unite health and wellness. I may also bring my guitar into the office from time to time."

Hackney built up significant health and wellness experience in the public/consumer world, working with Durex on AIDS prevention, with Johnson & Johnson on oral care and wound care, with Unilever on skin care and functional foods, and with other brands within cough and cold and babycare. In 2013, he sold Refreshed Wellbeing, the digitally based healthcare agency he co-founded, which had become one of the fastest-growing and most acclaimed independent digital healthcare/pharma-focused agencies in Europe. Under his leadership since 2014, McCann Health London was creatively recognized with Cannes Lions and Clio Awards and was the fastest-growing network health agency in the U.K.

For more information about Havas Health & You, visit HavasHealthandYou.com.

About Havas Health & You
Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Havas Life PR and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. Its customer-centric approach has the talent, tenacity and technology that health-and-wellness companies, brands and people need to thrive in today's world. For more information, go to www.HavasHealthandYou.com.

Contact:
Melanie Klausner
Havas PR
melanie.klausner@havas.com
M: 1-602-373-8131

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.